Incidence of Tumour Lysis Syndrome in Patients with Acute Myeloid Leukemia During Initiation of Therapy with Azacitidine and Venetoclax: A Retrospective Chart Review from a Canadian Single-Centre Perspective.

Curr Oncol · 2025 · PMC12026339 · PMID 40277769

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

did not quite reach statistical significancep = 0.06so close (0.05 < p ≤ 0.1)

The median baseline bone marrow blast % was higher in those patients who developed TLS by CB criteria compared to those patients who did not ( Table 1 ), but the difference did not quite reach statistical significance (65% vs. 30%, p = 0.06).

also in 679 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.